Search

everythinglearnresearchcommunity

for

Search:↓

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

A girl with Turner syndrome had psoriasis, alopecia areata, and trachyonychia.

Cancer treatments often cause skin, nail, and hair problems.

Keratosis pilaris is a common skin condition causing a bumpy texture, sometimes linked to other diseases, with various treatments available.

Understanding and treating alopecia areata improves patient care.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

FFA and FAPD might be related or stages of the same disease.

Personalized, multidisciplinary care improves skin condition management and patient outcomes.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.